α-tocopherol protects against cisplatin-induced toxicity without interfering with antitumor efficacy

Carlo Leonetti, Annamaria Biroccio, Chiara Gabellini, Marco Scarsella, Vittoria Maresca, Enrica Flori, Loredana Bove, Andrea Pace, Antonella Stopacciaro, Gabriella Zupi, Francesco Cognetti, Mauro Picardo

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Our aim was 2-fold: to investigate the role of α-tocopherol supplementation on the antitumor activity of DDP and to evaluate the effect of α-tocopherol on the survival and neurotoxicity of DDP-treated mice. Experiments performed on the M 14 human melanoma line demonstrated that α-tocopherol supplementation did not influence the efficacy of DDP; the inhibition of cell survival and of the in vivo tumor growth after treatment with α-tocopherol and DDP combination was similar to that observed after DDP alone. Conversely, α-tocopherol was also able to increase survival of mice treated with a high dose of DDP. While DDP alone produced death in about 70% of mice, the combination reduced deaths to about 30%. Analysis of oxidative stress markers and peroxidative damage in organs indicated that the protective effect of α-tocopherol was mainly related to its antioxidant activity. A significant increase in the concentration of TBARS and decreased PUFAs and catalase activity were observed after DDP treatment, while with α-tocopherol the levels of these markers were comparable to those observed in untreated mice. Histologic analysis performed on peripheral nerve revealed that α-tocopherol also protected mice from severe neurologic damage induced by DDP treatment. In conclusion, our results demonstrate that α-tocopherol protects against the systemic toxicity and neurotoxicity induced by DDP without interfering with its antitumor activity and suggest that this combination is a promising strategy to improve the therapeutic index of DDP-based chemotherapy.

Original languageEnglish
Pages (from-to)243-250
Number of pages8
JournalInternational Journal of Cancer
Volume104
Issue number2
DOIs
Publication statusPublished - Mar 20 2003

Fingerprint

Tocopherols
Cisplatin
Therapeutics
Peripheral Nerves
Catalase
Nervous System
Melanoma
Cell Survival
Oxidative Stress
Antioxidants
Drug Therapy
Survival

Keywords

  • Antineoplastic drug
  • Antioxidant
  • Chemoprotection
  • Combination treatment
  • Neuropathy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

α-tocopherol protects against cisplatin-induced toxicity without interfering with antitumor efficacy. / Leonetti, Carlo; Biroccio, Annamaria; Gabellini, Chiara; Scarsella, Marco; Maresca, Vittoria; Flori, Enrica; Bove, Loredana; Pace, Andrea; Stopacciaro, Antonella; Zupi, Gabriella; Cognetti, Francesco; Picardo, Mauro.

In: International Journal of Cancer, Vol. 104, No. 2, 20.03.2003, p. 243-250.

Research output: Contribution to journalArticle

@article{dfe4361f80344d3e85da30fd9595b7b2,
title = "α-tocopherol protects against cisplatin-induced toxicity without interfering with antitumor efficacy",
abstract = "Our aim was 2-fold: to investigate the role of α-tocopherol supplementation on the antitumor activity of DDP and to evaluate the effect of α-tocopherol on the survival and neurotoxicity of DDP-treated mice. Experiments performed on the M 14 human melanoma line demonstrated that α-tocopherol supplementation did not influence the efficacy of DDP; the inhibition of cell survival and of the in vivo tumor growth after treatment with α-tocopherol and DDP combination was similar to that observed after DDP alone. Conversely, α-tocopherol was also able to increase survival of mice treated with a high dose of DDP. While DDP alone produced death in about 70{\%} of mice, the combination reduced deaths to about 30{\%}. Analysis of oxidative stress markers and peroxidative damage in organs indicated that the protective effect of α-tocopherol was mainly related to its antioxidant activity. A significant increase in the concentration of TBARS and decreased PUFAs and catalase activity were observed after DDP treatment, while with α-tocopherol the levels of these markers were comparable to those observed in untreated mice. Histologic analysis performed on peripheral nerve revealed that α-tocopherol also protected mice from severe neurologic damage induced by DDP treatment. In conclusion, our results demonstrate that α-tocopherol protects against the systemic toxicity and neurotoxicity induced by DDP without interfering with its antitumor activity and suggest that this combination is a promising strategy to improve the therapeutic index of DDP-based chemotherapy.",
keywords = "Antineoplastic drug, Antioxidant, Chemoprotection, Combination treatment, Neuropathy",
author = "Carlo Leonetti and Annamaria Biroccio and Chiara Gabellini and Marco Scarsella and Vittoria Maresca and Enrica Flori and Loredana Bove and Andrea Pace and Antonella Stopacciaro and Gabriella Zupi and Francesco Cognetti and Mauro Picardo",
year = "2003",
month = "3",
day = "20",
doi = "10.1002/ijc.10933",
language = "English",
volume = "104",
pages = "243--250",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - α-tocopherol protects against cisplatin-induced toxicity without interfering with antitumor efficacy

AU - Leonetti, Carlo

AU - Biroccio, Annamaria

AU - Gabellini, Chiara

AU - Scarsella, Marco

AU - Maresca, Vittoria

AU - Flori, Enrica

AU - Bove, Loredana

AU - Pace, Andrea

AU - Stopacciaro, Antonella

AU - Zupi, Gabriella

AU - Cognetti, Francesco

AU - Picardo, Mauro

PY - 2003/3/20

Y1 - 2003/3/20

N2 - Our aim was 2-fold: to investigate the role of α-tocopherol supplementation on the antitumor activity of DDP and to evaluate the effect of α-tocopherol on the survival and neurotoxicity of DDP-treated mice. Experiments performed on the M 14 human melanoma line demonstrated that α-tocopherol supplementation did not influence the efficacy of DDP; the inhibition of cell survival and of the in vivo tumor growth after treatment with α-tocopherol and DDP combination was similar to that observed after DDP alone. Conversely, α-tocopherol was also able to increase survival of mice treated with a high dose of DDP. While DDP alone produced death in about 70% of mice, the combination reduced deaths to about 30%. Analysis of oxidative stress markers and peroxidative damage in organs indicated that the protective effect of α-tocopherol was mainly related to its antioxidant activity. A significant increase in the concentration of TBARS and decreased PUFAs and catalase activity were observed after DDP treatment, while with α-tocopherol the levels of these markers were comparable to those observed in untreated mice. Histologic analysis performed on peripheral nerve revealed that α-tocopherol also protected mice from severe neurologic damage induced by DDP treatment. In conclusion, our results demonstrate that α-tocopherol protects against the systemic toxicity and neurotoxicity induced by DDP without interfering with its antitumor activity and suggest that this combination is a promising strategy to improve the therapeutic index of DDP-based chemotherapy.

AB - Our aim was 2-fold: to investigate the role of α-tocopherol supplementation on the antitumor activity of DDP and to evaluate the effect of α-tocopherol on the survival and neurotoxicity of DDP-treated mice. Experiments performed on the M 14 human melanoma line demonstrated that α-tocopherol supplementation did not influence the efficacy of DDP; the inhibition of cell survival and of the in vivo tumor growth after treatment with α-tocopherol and DDP combination was similar to that observed after DDP alone. Conversely, α-tocopherol was also able to increase survival of mice treated with a high dose of DDP. While DDP alone produced death in about 70% of mice, the combination reduced deaths to about 30%. Analysis of oxidative stress markers and peroxidative damage in organs indicated that the protective effect of α-tocopherol was mainly related to its antioxidant activity. A significant increase in the concentration of TBARS and decreased PUFAs and catalase activity were observed after DDP treatment, while with α-tocopherol the levels of these markers were comparable to those observed in untreated mice. Histologic analysis performed on peripheral nerve revealed that α-tocopherol also protected mice from severe neurologic damage induced by DDP treatment. In conclusion, our results demonstrate that α-tocopherol protects against the systemic toxicity and neurotoxicity induced by DDP without interfering with its antitumor activity and suggest that this combination is a promising strategy to improve the therapeutic index of DDP-based chemotherapy.

KW - Antineoplastic drug

KW - Antioxidant

KW - Chemoprotection

KW - Combination treatment

KW - Neuropathy

UR - http://www.scopus.com/inward/record.url?scp=0037457391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037457391&partnerID=8YFLogxK

U2 - 10.1002/ijc.10933

DO - 10.1002/ijc.10933

M3 - Article

VL - 104

SP - 243

EP - 250

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 2

ER -